section 1 - World Intellectual Property Organization
section 1 - World Intellectual Property Organization
section 1 - World Intellectual Property Organization
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
44/2002<br />
21628 PCT Gazette - Section I - Gazette du PCT 31 Oct/oct 2002<br />
THE MINERALOCORTICOID RECEP-<br />
TOR<br />
METHODES DE TRAITEMENT AU<br />
MOYEN D’UN BLOQUEUR DE CA-<br />
NAL SODIQUE EPITHELIAL ET D’UN<br />
INHIBITEUR DU RECEPTEUR MINE-<br />
RALOCORTICOIDE<br />
(71) UAB RESEARCH FOUNDATION<br />
[US/US]; 701 20th Street South, #1120-G<br />
AB, Birmingham, AL 35294-0111 (US).<br />
(72) BUBIEN, James; 2505 Elizabeth Drive, Pelham,<br />
AL 35124 (US).<br />
(74) HENDRICKS, Glenna; P.O. Box 2509,<br />
Fairfax, VA 22031-2509 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ OM PH PL PT RO<br />
RU SD SE SG SI SK SL TJ TM TN TR TT<br />
TZ UA UG UZ VN YU ZA ZM ZW.<br />
(84)AP(GHGMKELSMWMZSDSLSZTZ<br />
UG ZM ZW); EA (AM AZ BY KG KZ MD<br />
RU TJ TM); EP (AT BE CH CY DE DK ES<br />
FI FR GB GR IE IT LU MC NL PT SE TR);<br />
OA(BFBJCFCGCICMGAGNGQGW<br />
ML MR NE SN TD TG).<br />
(51) 7 A61K 31/505, 31/616, A61P 7/02 // (A61K<br />
31/616, 31:505)<br />
(11) WO 02/085368<br />
(21) PCT/EP02/04129<br />
(13) A2<br />
(22) 13 Apr/avr 2002 (13.04.2002)<br />
(25) en (26) en<br />
(30) 101 19 680.6 20 Apr/avr 2001<br />
(20.04.2001)<br />
DE<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) USE OF RADICAL SCAVENGING<br />
COMPOUNDS FOR TREATMENT AND<br />
PREVENTION OF NO-DEPENDENT<br />
MICROCIRCULATION DISORDERS<br />
UTILISATION DE COMPOSES AN-<br />
TIRADICALAIRES DANS LE TRAI-<br />
TEMENT ET LA PREVENTION DE<br />
TROUBLES DE LA MICROCIRCULA-<br />
TION NO-DEPENDANTS<br />
(71) BOEHRINGER INGELHEIM PHARMA<br />
KG [DE/DE]; Binger Strasse 173, 55216 Ingelheim<br />
am Rhein (DE).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) EISERT, Wolfgang [DE/DE]; Nettelbeckstrasse<br />
19, 30175 Hannover (DE).<br />
(74) BOEHRINGER INGELHEIM PHARMA<br />
KG; Binger Strasse 173, 55216 Ingelheim/Rhein<br />
(DE).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ PH PL PT RO RU<br />
SD SE SG SI SK SL TJ TM TR TT TZ UA<br />
UG US UZ VN YU ZA ZW.<br />
(84)AP(GHGMKELSMWMZSDSLSZTZ<br />
UG ZM ZW); EA (AM AZ BY KG KZ MD<br />
RU TJ TM); EP (AT BE CH CY DE DK ES<br />
FI FR GB GR IE IT LU MC NL PT SE TR);<br />
OA(BFBJCFCGCICMGAGNGQGW<br />
ML MR NE SN TD TG).<br />
(51) 7 A61K 31/535<br />
(11) WO 02/085369 (13) A1<br />
(21) PCT/US02/09529<br />
(22) 26 Mar/mar 2002 (26.03.2002)<br />
(25) en (26) en<br />
(30) 09/818,259 26 Mar/mar 2001 US<br />
(26.03.2001)<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) INHIBITORS OF ANTHRAX LETHAL<br />
FACTOR ACTIVITY<br />
INHIBITEURS DE L’ACTIVITE DU<br />
FACTEUR LETHAL DE L’ANTHRAX<br />
(71) STRUCTURAL BIOINFORMATICS,<br />
INC. [US/US]; 10929 Technology Place, San<br />
Diego, CA 92127 (US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) RIDEOUT, Darryl [US/US]; 5058<br />
Sea Mist Court, San Diego, CA 92121<br />
(US). YALAMOORI, Venkatachalapathi<br />
[IN/IN]; 12246 Summerbreeze Lane,<br />
San Diego, CA 92128-3732 (US). RAM-<br />
NARAYAN, Kalyanaraman [IN/IN]; 11674<br />
Springside Road, San Diego, CA 92128<br />
(US). SHENDEROVICH, Mark [RU/RU];<br />
17488 Ashburton Road, San Diego, CA<br />
92128 (US). ZHENG, Jian Hua [US/US];<br />
8974 Adobe Bluffs Drive, San Diego, CA<br />
92129 (US). SUN, Jason [CN/CN]; 13397<br />
Russet Leaf Lane, San Diego. CA 92129<br />
(US). NIEMEYER, Christina [US/US];<br />
13156 Kellam Court, No. 128, San Diego,<br />
CA 92130 (US).<br />
(74) W ESEMAN, James, C.; The Law Offices of<br />
James C. Weseman, 401 West A Street, Suite<br />
1600, San Diego, CA 92101 (US).<br />
(81) AU CA JP US.<br />
(84)EP(ATBECHCYDEDKESFIFRGBGR<br />
IE IT LU MC NL PT SE TR).<br />
Published / Publiée : (c)<br />
Declarations / Déclarations :<br />
(s) for the following designations / pour les<br />
désignations suivantes : AU CA JP EP (AT BE<br />
CH CY DE DK ES FI FR GB GR IE IT LU MC<br />
NL PT SE TR)<br />
(t) for all designations / pour toutes les<br />
désignations<br />
(u) for / pour US only / seulement<br />
(51) 7 A61K 31/55, A61P 25/28, 25/30, 25/32,<br />
25/34, 25/36<br />
(11) WO 02/085370<br />
(21) PCT/EP02/04277<br />
(13) A1<br />
(22) 18 Apr/avr 2002 (18.04.2002)<br />
(25) de (26) de<br />
(30) 101 19 862.0 24 Apr/avr 2001<br />
(24.04.2001)<br />
DE<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) UTILIZATION OF GALANTHAMINE<br />
FOR THE TREATMENT OF PATHOLO-<br />
GIES OF THE CENTRAL NERVOUS<br />
SYSTEM OWING TO INTOXICATIONS<br />
WITH PSYCHOTROPIC SUBSTANCES<br />
UTILISATION DE GALANTHAMINE<br />
POUR TRAITER DES SYMPTOMES<br />
DU SYSTEME VERVEUX CENTRAL<br />
PROVOQUES PAR DES INTOXICA-<br />
TIONS DUES A DES SUBSTANCES<br />
PSYCHOTROPES<br />
(71) HF ARZNEIMITTELFORSCHUNG<br />
GMBH [DE/DE]; St. Johannes 5, 59368<br />
Werne (DE).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) OPITZ, Klaus [DE/DE]; Görlitzerstrasse<br />
102, 48157 Münster (DE). MOOR-<br />
MANN, Joachim [DE/DE]; Schulstrasse<br />
5, 59368 Werne (DE). HILLE, Thomas<br />
[DE/DE]; Am Moogsberg 2 A, 56567<br />
Neuwied (DE). BECHER, Frank [DE/DE];<br />
Keltenstrasse 84, 56072 Koblenz (DE).<br />
(74) FLACCUS, Rolf-Dieter; Bussardweg 10,<br />
50389 Wesseling (DE).<br />
(81) AU BG BR BY CA CN CO CZ EE HU ID IL<br />
IN JP KR LT LV MX NO NZ PH PL RO RU<br />
SG SI SK TR UA US ZA.<br />
(84) EA (AM AZ BY KG KZ MD RU TJ TM); EP<br />
(ATBECHCYDEDKESFIFRGBGRIE<br />
IT LU MC NL PT SE TR).<br />
Published / Publiée : (c)<br />
Declarations / Déclarations :<br />
(s) for the following designations / pour les<br />
désignations suivantes : AU BG BR BY CA CN<br />
CO CZ EE HU ID IL IN JP KR LT LV MX NO NZ<br />
PH PL RO RU SG SI SK TR UA ZA EA (AM AZ<br />
BY KG KZ MD RU TJ TM) EP (AT BE CH CY DE<br />
DK ES FI FR GB GR IE IT LU MC NL PT SE TR)<br />
(u) for / pour US only / seulement<br />
(51) 7 A61K 31/554, 31/135, 31/553<br />
(11) WO 02/085371 (13) A1<br />
(21) PCT/US02/12433<br />
(22) 19 Apr/avr 2002 (19.04.2002)<br />
(25) en (26) en<br />
(30) 09/839,605 20 Apr/avr 2001 US<br />
(20.04.2001)<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) NONINVASIVE METHOD FOR TREAT-<br />
ING CELLULITE THROUGH TRANS-<br />
DERMAL DELIVERY OF CALCIUM<br />
CHANNEL BLOCKER AGENTS AND<br />
MEDICAMENT FOR USE IN SUCH<br />
METHOD<br />
METHODE NON INVASIVE DE TRAI-<br />
TEMENT DE LA CELLULITE PAR AD-<br />
MINISTRATION TRANSDERMIQUE<br />
D’AGENTS DE BLOCAGE DES CA-<br />
NAUX CALCIQUES ET MEDICAMENT<br />
UTILISE DANS LADITE METHODE<br />
(63) US 09/839,605 (CON)<br />
20 Apr/avr 2001 (20.04.2001)<br />
(71, 72) EASTERLING, W., Jerry [US/US];<br />
Suite 204, 19230 Stone Oak Parkway, San<br />
Antonio, TX 76758 (US).<br />
(74) HENRY, David, G.; 900 Washington Avenue,<br />
P.O. Box 1470, Waco, TX 76703-1470<br />
(US).<br />
(81) AL AM AT AU AZ BA BB BG BR BY CA<br />
CH CN CU CZ DE DK EE ES FI GB GE GH<br />
GM HR HU ID IL IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MD MG MK MN<br />
MW MX NO NZ PL PT RO RU SD SE SG<br />
SI SK SL TJ TM TR TT UA UG US UZ VN<br />
YU ZW.<br />
(84)AP(GHGMKELSMWMZSDSLSZTZ<br />
UG ZM ZW); EA (AM AZ BY KG KZ MD<br />
RUTJTM);EP(ATBECHCYDEDKES